We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+20.87%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$38.4B
AUM Growth
+$3.99B
Cap. Flow
-$1.06B
Cap. Flow %
-2.76%
Top 10 Hldgs %
28.98%
Holding
520
New
61
Increased
186
Reduced
165
Closed
55

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$202M
2
QCOM icon
Qualcomm
QCOM
+$182M
3
DKNG icon
DraftKings
DKNG
+$177M
4
AMD icon
Advanced Micro Devices
AMD
+$160M
5
FISV
Fiserv Inc
FISV
+$152M

Sector Composition

Rank Sector Weight
1 Technology 35.81%
2 Healthcare 20.96%
3 Consumer Discretionary 14.53%
4 Communication Services 9.02%
5 Financials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
276
Eli Lilly
LLY
$1.03T
$5.07M 0.01%
30,000
-40,521
-57% -$6.05M
EB
277
DELISTED
Eventbrite
EB
$4.95M 0.01%
273,529
+30,687
+13% +$430K
CMRC
278
Commerce.com Inc Series 1
CMRC
$261M
$4.86M 0.01%
75,820
+69,080
+1,025% +$5.52M
FICO icon
279
Fair Isaac
FICO
$24.6B
$4.86M 0.01%
9,508
-4,828
-34% -$2.25M
PANW icon
280
Palo Alto Networks
PANW
$265B
$4.84M 0.01%
81,750
-24,270
-23% -$1.13M
TEAM icon
281
Atlassian
TEAM
$24.9B
$4.71M 0.01%
20,155
+6,069
+43% +$1.28M
BBBY
282
DELISTED
Bed Bath & Beyond Inc
BBBY
$4.68M 0.01%
263,770
-32,536
-11% -$675K
PG icon
283
Procter & Gamble
PG
$335B
$4.54M 0.01%
32,662
-2,077
-6% -$290K
TGTX icon
284
TG Therapeutics
TGTX
$8.19B
$4.53M 0.01%
87,052
+20,778
+31% +$702K
CHEF icon
285
Chefs' Warehouse
CHEF
$4.58B
$4.51M 0.01%
175,538
+95,422
+119% +$1.88M
REAL icon
286
The RealReal
REAL
$1.44B
$4.47M 0.01%
228,804
+108,962
+91% +$1.68M
PEP icon
287
PepsiCo
PEP
$191B
$4.31M 0.01%
29,078
+1,316
+5% +$187K
HDB icon
288
HDFC Bank
HDB
$124B
$4.26M 0.01%
118,000
EW icon
289
Edwards Lifesciences
EW
$50B
$4.26M 0.01%
46,666
-1,148
-2% -$95.2K
SPWH icon
290
Sportsman's Warehouse
SPWH
$45.3M
$4.1M 0.01%
233,393
-118,613
-34% -$1.74M
GRFS
291
Grifois
GRFS
$5.58B
$4.08M 0.01%
221,538
AVGO icon
292
Broadcom
AVGO
$1.85T
$3.95M 0.01%
90,130
INGN icon
293
Inogen
INGN
$174M
$3.94M 0.01%
88,167
+8,855
+11% +$306K
JNJ icon
294
Johnson & Johnson
JNJ
$617B
$3.92M 0.01%
24,908
-84
-0.3% -$12.4K
BLK icon
295
Blackrock
BLK
$170B
$3.89M 0.01%
5,391
-559
-9% -$371K
SAGE
296
DELISTED
Sage Therapeutics
SAGE
$3.62M 0.01%
41,830
-105,738
-72% -$7.79M
MRTX
297
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.57M 0.01%
16,263
+4,890
+43% +$1.06M
TCRR
298
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$3.54M 0.01%
+114,358
New +$2.89M
AZN icon
299
AstraZeneca
AZN
$266B
$3.45M 0.01%
34,469
-36,106
-51% -$3.82M
MA icon
300
Mastercard
MA
$510B
$3.45M 0.01%
9,653
+9,289
+2,552% +$3.09M

Similar funds

Fred Alger Management's Q4 2020 Portfolio in Review

As of Q4 2020, Fred Alger Management held 520 positions worth $38.4B, up 12% from $34.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Fred Alger Management's Q4 2020 filing shows 61 new, 186 increased, 165 reduced and 55 closed positions. Its largest new stake was RBC Bearings: 850,381 shares worth $152M. The largest sale was Alibaba, an estimated $530M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Fred Alger Management's largest Q4 2020 buy was RBC Bearings: 850,381 shares worth $152M.
  • Fred Alger Management added most to CME Group in Q4 2020, an estimated $202M increase.
  • Fred Alger Management's biggest Q4 2020 reduction was Alibaba, cutting an estimated $530M.
  • Fred Alger Management fully exited Alteryx Inc in Q4 2020, selling an estimated $63.6M.
  • Fred Alger Management's ten largest holdings make up 29% of its $38.4B portfolio in Q4 2020.
  • Fred Alger Management opened 61 new positions and closed 55 in Q4 2020.
  • Fred Alger Management's portfolio value rose 12% quarter-over-quarter to $38.4B.

Based on Fred Alger Management's 13F filing for Q4 2020, filed 16 Feb 2021.